ORAGENICS, INC. Increase (Decrease) in Other Receivables
ORAGENICS, INC. (OGEN) reported Increase (Decrease) in Other Receivables of $53.08 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-03-16
- ORAGENICS, INC. increase (decrease) in other receivables for the quarter ending 2023-09-30 was $21.94K.
- ORAGENICS, INC. increase (decrease) in other receivables for the quarter ending 2022-12-31 was $0.00.
- ORAGENICS, INC. increase (decrease) in other receivables for the quarter ending 2022-09-30 was $0.00.
- ORAGENICS, INC. increase (decrease) in other receivables for the quarter ending 2022-06-30 was $0.00.
- ORAGENICS, INC. increase (decrease) in other receivables for fiscal 2025 was $53.08K.
- ORAGENICS, INC. increase (decrease) in other receivables for fiscal 2022 was -$6.99K, a 200.00% decline from fiscal 2021.
- ORAGENICS, INC. increase (decrease) in other receivables for fiscal 2021 was $6.99K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2025-12-31 | $53.08K 10-K · filed 2026-03-16 | |||
| 2023-09-30 | $21.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $35.10K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $13.16K 10-Q · filed 2024-08-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | -$6.99K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$6.99K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$6.99K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$6.99K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $6.99K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |